Baillie Gifford Health Fund Current Valuation
| BGHBX Fund | USD 5.82 0.02 0.34% |
Valuation analysis of Baillie Gifford Health helps investors to measure Baillie Gifford's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
Please note that Baillie Gifford's price fluctuation is not too volatile at this time. At this time, the entity appears to be fairly valued. Baillie Gifford Health shows a prevailing Real Value of $5.82 per share. The current price of the fund is $5.82. We determine the value of Baillie Gifford Health from analyzing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we favor acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will blend.
Since Baillie Gifford is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Baillie Mutual Fund. However, Baillie Gifford's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.82 | Real 5.82 | Hype 5.82 | Naive 6.03 |
The intrinsic value of Baillie Gifford's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Baillie Gifford's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Baillie Gifford Health helps investors to forecast how Baillie mutual fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Baillie Gifford more accurately as focusing exclusively on Baillie Gifford's fundamentals will not take into account other important factors: Baillie Gifford Health Mutual Fund Current Valuation Analysis
Baillie Gifford's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Baillie Gifford Health has a Current Valuation of 0.0. This indicator is about the same for the Baillie Gifford Funds average (which is currently at 0.0) family and about the same as Health (which currently averages 0.0) category. This indicator is about the same for all United States funds average (which is currently at 0.0).
Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
| All Next | Launch Module |
Baillie Fundamentals
| Year To Date Return | 0.34 % | ||||
| One Year Return | 7.58 % | ||||
| Net Asset | 15.42 M |
About Baillie Gifford Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Baillie Gifford Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Baillie Gifford using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Baillie Gifford Health based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Baillie Mutual Fund
Baillie Gifford financial ratios help investors to determine whether Baillie Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Baillie with respect to the benefits of owning Baillie Gifford security.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |